Detalhe da pesquisa
1.
Acetylation-dependent regulation of Skp2 function.
Cell
; 150(1): 179-93, 2012 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-22770219
2.
Light-Activated Nanodiamond-Based Drug Delivery Systems for Spatiotemporal Release of Antisense Oligonucleotides.
Bioconjug Chem
; 35(5): 623-632, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38659333
3.
Inhibition of Rb Phosphorylation Leads to mTORC2-Mediated Activation of Akt.
Mol Cell
; 62(6): 929-942, 2016 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27237051
4.
High Throughput Confined Migration Microfluidic Device for Drug Screening.
Small
; 19(16): e2207194, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634971
5.
Akt-ing up on SRPK1: oncogene or tumor suppressor?
Mol Cell
; 54(3): 329-30, 2014 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24813709
6.
mTOR drives its own activation via SCF(ßTrCP)-dependent degradation of the mTOR inhibitor DEPTOR.
Mol Cell
; 44(2): 290-303, 2011 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22017875
7.
The actin-bundling protein palladin is an Akt1-specific substrate that regulates breast cancer cell migration.
Mol Cell
; 38(3): 333-44, 2010 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-20471940
8.
An integrated and multi-functional droplet-based microfluidic platform for digital DNA amplification.
Biosens Bioelectron
; 246: 115831, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38008058
9.
TNA-Mediated Antisense Strategy to Knockdown Akt Genes for Triple-Negative Breast Cancer Therapy.
Small Methods
; : e2400291, 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38779741
10.
3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor-on-a-Chip.
Adv Healthc Mater
; 12(18): e2202609, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36917657
11.
NFAT promotes carcinoma invasive migration through glypican-6.
Biochem J
; 440(1): 157-66, 2011 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21871017
12.
Upregulation of Receptor Tyrosine Kinase Activity and Stemness as Resistance Mechanisms to Akt Inhibitors in Breast Cancer.
Cancers (Basel)
; 14(20)2022 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36291790
13.
Cellular uptake, tissue penetration, biodistribution, and biosafety of threose nucleic acids: Assessing in vitro and in vivo delivery.
Mater Today Bio
; 15: 100299, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35637854
14.
ANLN Enhances Triple-Negative Breast Cancer Stemness Through TWIST1 and BMP2 and Promotes its Spheroid Growth.
Front Mol Biosci
; 8: 700973, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34277708
15.
Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling.
Nat Commun
; 12(1): 2242, 2021 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33854062
16.
Cancer stem cells: advances in biology and clinical translation-a Keystone Symposia report.
Ann N Y Acad Sci
; 1506(1): 142-163, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34850398
17.
Akt/protein kinase b and glycogen synthase kinase-3beta signaling pathway regulates cell migration through the NFAT1 transcription factor.
Mol Cancer Res
; 7(3): 425-32, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19258413
18.
Akt3 promotes cancer stemness in triple-negative breast cancer through YB1-Snail/Slug signaling axis.
Genes Dis
; 10(2): 301-306, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37223515
19.
Upregulation of AKT3 Confers Resistance to the AKT Inhibitor MK2206 in Breast Cancer.
Mol Cancer Ther
; 15(8): 1964-74, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27297869
20.
PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex.
Cancer Discov
; 5(11): 1194-209, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26293922